September 4, 2024
“…COMPASS Pathways (CMPS)… Morgan Stanley analyst Vikram Purohit, who covers the stock, sees CMPS as presenting a compelling risk-reward opportunity. He highlights the company’s leading clinical program… To this end, Purohit rates CMPS shares an Overweight (i.e. Buy), and his $23 price… Continue Reading…
August 12, 2024
“CervoMed (CRVO) The first Morgan Stanley pick we’ll look at is CervoMed, a clinical-stage medical research firm specializing in neurodegenerative diseases and conditions… Overall, the analyst expects positive clinical results and rates CRVO an Overweight (i.e., Buy). His $35 price… Continue Reading…
August 1, 2024
“Twelve stocks in the S&P 500, including Walgreens Boots Alliance (WBA), Dexcom (DXCM) and Super Micro Computer (SMCI), have already crashed 40% or more from their 52-week highs, says an Investor’s Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge. A 40% decline is… Continue Reading…
July 29, 2024
“…“To date, the broad financial stability implications of changes in retail equity investor characteristics and behaviors have been limited,” the Fed said. The central bank specifically assessed what happened to shares of AMC Entertainment and GameStop in January, noting that activity and… Continue Reading…
July 2, 2024
“…1. Summit Therapeutics Summit Therapeutics (NASDAQ: SMMT) is sizzling hot this year, with its shares skyrocketing around 220%. All of this huge gain has come since late May… 2. Super Micro Computer Shares of Super Micro Computer (NASDAQ: SMCI) have nearly tripled so far in… Continue Reading…
June 5, 2024
“… …” https://finance.yahoo.com/news/bofa-says-chip-stocks-wont-013254042.html 2026 is the peak? The economy will more than likely collapse before then. Everyone sees what’s happening in the EV market. Now investing in cars after the crash might be a good idea but before? No. That’s… Continue Reading…
May 21, 2024
“Sutro Biopharma (STRO)… “We think that luvelta has the potential to treat up to 80% of PROC patients, a significant improvement over the ~30% eligible for AbbVie’s Elahere (approved FolRα ADC)… Overall, the Strong Buy consensus rating on STRO is based… Continue Reading…
April 30, 2024
https://finance.yahoo.com/news/stocks-going-crash-joe-biden-090600124.html This article is garbage so I’ll just comment on the headline. This is my opinion on whats going to happen. The market is going to crash either way but outcomes will be different depending on who’s President. Under Biden… Continue Reading…
April 24, 2024
“Technology stocks were broadly showing signs of “breaking down,” as the sector struggles in a slump this month that has deepened significantly, according to Bespoke Investment Group. The S&P 500’s information-technology sector tumbled 7.3% last week, its biggest weekly drop… Continue Reading…
April 23, 2024
“…There are two potential issues Wall Street and investors might have with a Republican-controlled Congress and Trump at the helm. To start with, Republicans may aim to pass tax reforms that would reduce corporate and personal income-tax rates. While people… Continue Reading…
Recent Comments